Trial Profile
Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2014
Price :
$35
*
At a glance
- Drugs Finafloxacin (Primary)
- Indications Bacterial infections; Otitis media
- Focus Therapeutic Use
- Sponsors Alcon
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2013 Planned End Date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 17 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.